Current Opinion in Neurology was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of neurology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Bruce H. Dobkin, is Professor of Neurology at the University of California Los Angeles Geffen School of Medicine, Medical Director of the UCLA Neurologic Rehabilitation and Research Program and co-director of the Stroke Center. He is an honorary fellow of the Royal College of Physicians, and elected fellow of the American Neurological Association and American Academy of Neurology. He has served on the Board of Directors of the American Society of Neurorehabilitation and as managing director of the World Federation of NeuroRehabilitation. He chaired the Section on Neural Repair and Rehabilitation of the AAN and the education and scientific programs for the ASNR, WFNR, and AAN. He is Editor-in-Chief of Neurorehabilitation and Neural Repair. He is the single author of the text, The Clinical Science of Neurologic Rehabilitation (Oxford U. Press, 2003) and a novel about doctoring, Brain Matters: Stories of a Neurologist and His Patients (Crown Publ, 1986) He has published over 100 peer-reviewed manuscripts around his research interests in motor control, recovery of walking, functional neuroimaging and clinical trials in stroke and spinal cord injury. His 20 book chapters related to neurorehabilitation include Neurology in Clinical Practice and Stroke: Pathophysiology, Diagnosis, and Management.
Gabriella Bottini is Professor of Psychobiology and Neuropsychology at the University of Pavia, Italy and Director of the Cognitive Neuropsychology Center of the Niguarda Ca' Granda Hospital of Milan, Italy. She is a member of the International Neuropsychological Symposium, of the European Neuropsychology Society, of the Itanian Neuropsychological Society, of the Italian League against Epilepsy of which she coordinates the Neuropsychology Study group. Her research areas of interest are: unilateral neglect, body representation disorders, neuropsychology of epilepsy and of dementia, functional neuroimaging applied to neuropsychology. She is author of two books, of several chapters in and of forty peer-reviewed manuscripts in international journals including Nature, Science, and Brain.
Michael Weller is Professor and Chairman of the Department of Neurology, University Hospital Zurich, Switzerland, since 2008. He received his MD degree at the University of Cologne, Germany (1989) and was trained at the Universities of Tübingen (Neurology) and Würzburg (Psychiatry) in Germany (1990–1991), the National Institute of Mental Health, Bethesda, MD, USA (1992), the University Hospital Zurich (Clinical Immunology) in Switzerland (1993–1994) and again the University of Tübingen, Germany (since 1995) where he was appointed Chairman from 2005-2007. He was the Chairman of the German Neuro-Oncology Group from 2001 to 2008 and has served as the Chairman of the German Glioma Network since 2004. His research interests focus on the immunology of brain tumors and the initiation and conduct of clinical trials in Neuro-Oncology.
Roger Stupp is the chairman of the Department of Oncology/Hematology of the Riveria and Chablais region in the French part of Switzerland. He is also the head of the neuro-oncology unit at the Department of neurosurgery at the University of Lausanne. Dr Stupp went to Medical School at University of Zurich, and then trained in Internal Medicine in Switzerland and in Hematology/Oncology at the University of Chicago. He is a member of the European Organization for Research and Treatment of Cancer (EORTC), and was secretary of the Brain Tumor Group (2003–2009), and chairman of the Clinical Research Division (2006–2009). He currently serves as the Vice-president of the organization. His research interest is on new anticancer agents, and their combination with radiotherapy. His clinical focus is on treatment of glioma.